N-α-Fmoc-N-γ-Z-D-2,4-diaminobutyric acid

N-α-Fmoc-N-γ-Z-D-2,4-diaminobutyric acid is a D-configured, diamino acid derivative bearing an N-α Fmoc protecting group and a γ-Z (benzyloxycarbonyl) protecting group, with two amino functionalities positioned on a short, four-carbon backbone. The molecule contains an Fmoc carbamate and a Z-protected amine that modulate nucleophilicity and enable orthogonal deprotection strategies during peptide assembly. The presence of two stereochemically relevant amino-bearing sites supports controlled side-chain functionalization, while the protected groups provide chemical stability under coupling conditions and compatibility with standard solid-phase or solution-phase peptide synthesis workflows. The protected diamino acid structure also serves as a chiral, amino acid-based intermediate for downstream conversion into selectively deprotected building blocks and functionalized peptidomimetics.

1. Protected Diamino Peptide Building Block

N-α-Fmoc-N-γ-Z-D-2,4-diaminobutyric acid is used in peptide synthesis workflows where a protected diamino acid building block is required to introduce a defined, D-configured 2,4-diaminobutyric motif into peptide chains. The Fmoc group supports N-terminal protection and base-labile removal, while the γ-Z carbamate provides orthogonal protection for the additional amino functionality during iterative coupling cycles. The orthogonally protected diamine enables selective exposure of one amino group for subsequent coupling or for controlled branching reactions, supporting C-terminal or side-chain elaboration without uncontrolled cross-reactions. The resulting peptides and peptide fragments can be used to generate sequence-defined analogs and to study how diamino spacing influences backbone conformation and side-chain recognition in biochemical assays.

2. Orthogonal Deprotection Chemistry

N-α-Fmoc-N-γ-Z-D-2,4-diaminobutyric acid is applied in synthetic organic chemistry and peptide chemistry as a chiral intermediate designed for orthogonal deprotection logic. The Fmoc carbamate is compatible with base-mediated removal, whereas the γ-Z protecting group can be addressed under hydrogenolysis conditions, allowing sequential unveiling of the α- and γ-amines. The two protected amino groups act as controlled nucleophiles, enabling stepwise derivatization such as selective acylation, sulfonylation, or coupling to electrophiles after one deprotection event. Downstream, the selectively deprotected diamino acid derivatives can be incorporated into peptidomimetics, used to generate constrained linkers, or converted into functional scaffolds for chemical biology and structure-function studies.

3. Bioconjugation Linker Synthesis

N-α-Fmoc-N-γ-Z-D-2,4-diaminobutyric acid is suitable for bioconjugation chemistry where protected diamino handles are required to build defined amine-rich linkers and conjugation-ready intermediates. The protected amines allow the compound to be carried through peptide coupling or fragment assembly steps without premature reaction with activated esters, isothiocyanates, or aldehyde-derived electrophiles. Sequential deprotection can generate a controlled primary amine pattern, supporting conjugation strategies that attach biomolecules, probes, or affinity tags while maintaining stereochemical integrity of the D-2,4-diaminobutyric segment. The resulting conjugation intermediates can be used to construct labeled peptides, antibody fragments, or nucleic-acid-binding constructs where diamino spacing affects solubility, charge distribution, and binding-site accessibility.

4. Peptidomimetic And SAR Studies

N-α-Fmoc-N-γ-Z-D-2,4-diaminobutyric acid is employed in drug discovery research and SAR studies focused on peptidomimetic design and amino acid substitution mapping. The D-configuration and diamino side-chain architecture can be incorporated into peptide analogs to probe how stereochemistry and side-chain charge topology influence target binding and proteolytic stability trends in assay formats. The Fmoc/Z-protected framework supports systematic library synthesis by enabling controlled incorporation into short sequences followed by selective functional group transformations at the exposed amine site. Downstream derivatives can be used to generate structure-activity relationship datasets for analog optimization, while the protected diamino acid itself functions as a reproducible chiral building block in medicinal chemistry synthesis campaigns.

5. Pharmaceutical Intermediate Manufacture

N-α-Fmoc-N-γ-Z-D-2,4-diaminobutyric acid is relevant to pharmaceutical manufacturing and fine chemical synthesis as a protected, chiral amino acid intermediate that can be produced and handled in a protected form to meet process compatibility requirements. The Fmoc carbamate and γ-Z carbamate provide stability against undesired side reactions during storage and coupling operations, supporting predictable reactivity in controlled manufacturing steps. The orthogonal protecting groups can be leveraged to design manufacturing routes that incorporate the diamino acid motif into peptide intermediates, followed by staged deprotection and downstream conversion to API-related fragments or reference standards. The compound's protected diamino functionality also supports scalable synthesis of defined peptidic or peptidomimetic intermediates used in applied product development and process chemistry optimization.

1. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

2. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

3. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

4. The spatiotemporal control of signalling and trafficking of the GLP-1R

5. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides